The Rcs phosphorelay signal transduction system of Escherichia coli controls genes for capsule production and many other envelope-related functions and is implicated in biofilm formation. The outer-membrane lipoprotein RcsF is an essential component of the Rcs system. Mislocalization of RcsF to the periplasm or the cytoplasmic membrane leads to high activation of the Rcs system, suggesting that RcsF functions by interacting with the cytoplasmic membrane component(s) of the system in activating the system. This is consistent with the result reported by Cho et al. (Cell 159, 1652-1664 showing that RcsF interacts with the periplasmic domain (YrfFperi) of the inner-membrane protein YrfF (IgaA in Salmonella enterica serovar Typhimurium), which is a negative regulator of the Rcs system. In this study we show that RcsF also interacts with the periplasmic domain of the innermembrane-localized histidine kinase RcsC (RcsCperi). RcsCperi, which was secreted to the periplasm by fusion to maltose-binding protein, titrated RcsF's activating effect. A bimolecular fluorescence complementation experiment showed interaction of RcsF with RcsCperi, as well as with YrfFperi. We conclude that RcsF interacts with the periplasmically exposed region of RcsC, as well as with that of YrfF.
INTRODUCTION
The enterobacterial Rcs phosphorelay system is a complex signal transduction system [1] . Responding to envelope stresses, the cytoplasmic membrane (CM)-localized histidine kinase RcsC autophosphorylates at the conserved His residue. RcsC is a hybrid-type histidine kinase that contains an additional receiver domain. The phosphoryl group is transferred to the conserved Asp residue in the receiver domain. Phosphotransfer to the conserved His residue in the CM-localized transmitter protein RcsD (also called YojN) follows. Finally, the phosphoryl group is transferred to the conserved Asp residue in the cytoplasmic response regulator RcsB.
In addition to these phosphorelay components, the outermembrane (OM) lipoprotein RcsF and a CM protein, YrfF (IgaA in Salmonella enterica serovar Typhimurium) are involved in the Rcs system. RcsF was first identified as activating the Rcs system when overproduced [2] . For a variety of environmental and mutational stresses that stimulate the Rcs system, the stimulation depends on RcsF [1, 3] , and RcsF is now regarded as an essential component of the Rcs system. RcsF is an OM lipoprotein with an unusual topology. Its lipid moiety modifying the N terminus is anchored in the outer leaflet of the OM, whereas its C-terminal domain resides in the periplasm. The transmembrane domain is threaded through the lumen of b-barrel OM proteins. This structure is formed by the Bam complex, which assembles OM b-barrel proteins [4] .
YrfF was first identified in S. Typhimurium as increasing the intracellular proliferation rate when mutated [5] and was named IgaA since it acted as the intracellular growth attenuator in S. Typhimurium. YrfF is a negative regulator of the Rcs system [6] . The gene, yrfF, is an essential gene.
The lethality of a yrfF null mutation is suppressed by a null mutation of rcsC, rcsD or rcsB. Absence of YrfF causes overactivation of the Rcs system, which is most likely the cause of lethality.
Mislocalization of RcsF to the periplasm, effected by fusing it to the periplasmic maltose-binding protein (MBP), or mislocalization to the CM, which can be brought about by changing the lipoprotein sorting signal, leads to high activation of the Rcs system, suggesting that RcsF functions by interacting with the CM component(s) of the system in activating the system [7] . Cho et al. [8] reported that RcsF interacts directly with the large periplasmic domain of YrfF (YrfFperi). They suggested that this interaction interferes with the negative regulatory function of YrfF, leading to the Rcs activation.
On the other hand, we suspected that RcsF might interact with the periplasmic domain of CM histidine kinase RcsC (RcsCperi) [7] . In this study we examine this possibility. Release of RcsCperi to the periplasm by fusing it with MBP titrated out RcsF's activating effect. MBP-YrfFperi also titrated out RcsF's activating effect. Bimolecular fluorescence complementation (BiFC) experiments showed evidence of the interaction of RcsF with RcsC and YrfF in the periplasm.
METHODS
Bacterial strains, plasmids and culture media The strains and the plasmids used for this study are listed in Table 1 . The DNA primers used for this study are listed in Table S1 (available in the online Supplementary Material).
The strain and plasmid construction is described in the Supplementary Material.
Luria-Bertani (LB) medium was used. For plates, media were solidified with 1.5 % agar. When appropriate, antibiotics were included at the following concentrations (in µg ml À1 ): ampicillin, 50; chloramphenicol, 50; kanamycin, 50; tetracycline, 15; spectinomycin, 50. X-Gal was used at 40 µg ml À1 to examine the b-galactosidase levels of colonies on LB agar medium.
Cells were grown at 30 C. Growth was monitored with a mini-photo 518R photometer (TAITEC) equipped with a 530 nm interference filter.
Genetic and recombinant DNA procedures These were based on standard methods [9, 10] .
Biochemical procedures
Rcs activity was monitored by b-galactosidase activity expressed from cpsB¢-lacZ operon fusion [11] . The b-galactosidase assay was carried out for cells grown in LB medium at 30 C to the mid-exponential phase (mini-photo 518R photometer reading of 0.47). The assay method using ONPG as the substrate and the unit definition were as described by Wang and Doi [12] .
For protein analyses by SDS-PAGE in 10 % polyacrylamide gel, cells were grown in LB medium at 30 C to the midexponential phase (mini-photo reading of 0.47). Luminata Forte Western HRP substrate (Millipore) was used for immunodetection in Western blotting experiments according to the manufacturer's instructions. Anti-RcsF antiserum, raised against C-terminally His 6 -tagged RcsF lacking its signal sequence and N-terminal Cys of the mature form [7] , was used. Anti-MBP monoclonal antibody and anti-DYKDDDK tag (FLAG tag) monoclonal antibody were purchased from New England Biolabs and Wako Pure Chemicals, respectively. The secondary antibodies used for Western analysis were peroxidase-conjugated AffiniPure goat anti-rabbit IgG (H+L) and peroxidase-conjugated AffiniPure goat anti-mouse IgG (H+L) (Jackson ImmunoResearch Laboratories). Western analysis bands were detected by C-Digit scanner (LI-COR).
BiFC
The gene for superfolder GFP (sfGFP) [13] was constructed based on mVenus, which carries the monomerizing A206K mutation (http://www.snapgene.com/resources/plasmid_ files/fluorescent_protein_genes_and_plasmids/mVenus/), using mutagenic oligonucleotides, and cloned on pBluescriptIISK(+) (S. Matsuoka, unpublished result). Thus, this sfGFP is a monomeric variant of GFP. We split sfGFP into two fragments: sfGN (from the N terminus to the 173rd residue) and sfGC (from the 155th residue to the C terminus) [14] . The signal sequence (SS) of MBP was fused to the N terminus of each fragment. Two periplasmic BiFC vectors in which MBP SS-sfGN and MBP SS-sfGC were expressed from P trc on pBR322-and p15A-derived plasmids, respectively, were constructed. Microscopic observations were conducted as described previously [15] .
RESULTS
MBP-RcsCperi titrated the activating effect of RcsF in an opgH mutant in the N-terminal region of RcsC are predicted to be sandwiched by transmembrane sequences and exposed to the periplasm [16] (we changed the residue numbering so that the TTG codon 16 codons upstream of the ATG codon reported by Stout and Gottesman [16] is regarded as the initiation codon in this study). This segment (RcsCperi) was fused to the malE gene encoding MBP in the plasmid pAT026. The fusion gene was under the control of IPTG-inducible P tac promoter. The renamed opgH (formerly called mdoH) mutation leading to a lack of osmoregulated periplasmic glucan activates the Rcs system [17] . For this activation RcsF is required [3] . When pAT026 was introduced into the opgH mutant CL034 with cpsB¢-lacZ fusion, b-galactosidase activity was decreased, indicating that the Rcs activation level was decreased (Fig. 1a) . With the addition of IPTG the level decreased further. When the cells induced with 500 µM IPTG were fractionated into the periplasmic and spheroplast fractions, at least part of MBPRcsCperi was recovered in the periplasmic fraction MBP-RcsCperi titrated out the activating effect of the periplasmic version of RcsF When RcsF is mislocalized to the periplasm by fusion of the mature form of RcsF to periplasmic MBP, the Rcs system is strongly activated [7] . For this study we fused the mature form of RcsF to MBP SS, and placed the fusion gene under the arabinose-inducible P BAD promoter [18] . The product should be periplasmically mislocalized RcsF. The DrcsF host strain TA005 lacks the high-affinity arabinose transporter (DaraFGH) and carries the gene for the low-affinity highcapacity transporter (araE) under the control of an arabinose-independent constitutive promoter (P CP18 ), thus allowing homologous expression of the P BAD -controlled gene (otherwise, P BAD -controlled genes are expressed in an all-or-nothing fashion, leading to intermediate expression levels in cultures at subsaturating inducer concentrations reflecting the population average of induced and uninduced cells rather than the degree of induction in individual cells) [19, 20] . In the absence of MBP-RcsCperi, increasing the arabinose concentration from 0 to 0.0002 % resulted in increasing Rcs activity due to periplasmically mislocalized RcsF (Fig. 1b, top) . At inducer concentrations higher than 0.002 % periplasmic RcsF strongly activated the Rcs system to an almost saturated level. When P tac -controlled MBPRcsCperi was expressed with 500 µM IPTG, Rcs activation was almost completely abolished at arabinose concentrations from 0 to 0.0002 % (Fig. 1b, bottom) . This result #SS, Signal sequence. **sfGN codes for a fragment from the N terminus to the 173rd residue of sfGFP. † †sfGC codes for a fragment from the 155th residue to the C terminus of sfGFP. ‡ ‡zip codes for a leucine zipper of the yeast transcriptional factor GCN4. § §P 204 is a weakened version of P trc [48] .
suggests that MBP-RcsCperi interacted with periplasmic RcsF and prevented it from interacting with RcsC in the CM. At arabinose concentrations higher than 0.002 % no inhibition of Rcs activation by MBP-RcsCperi was observed, probably because the number of periplasmic RcsF molecules exceeded the number of MBP-RcsCperi molecules, although we did not compare the amounts of periplasmic RcsF and MBP-RcsCperi under these conditions.
RcsF has a characteristic region (residues 17-35 in the mature form) rich in proline and basic amino acid residues (proline-rich region, PRR). Deletion of the PRR in periplasmically mislocalized RcsF increases the Rcs activating effect [21] . Arabinose-controlled RcsFDPRR was expressed in the periplasm at inducer concentrations of 0 and 0.0002 %. Expression of IPTG-controlled MBP-RcsCperi with 500 µM IPTG almost completely abolished the Rcs activation (Fig. 1c) . MBP-RcsCperi thus also titrated out the Rcs-activating effect of RcsFDPRR.
MBP-YrfFperi titrated out the activating effect of the periplasmic version of RcsF Cho et al. [8] reported that YrfFperi (residues 361-655) interacts with RcsF. Consequently, when YrfFperi is fused to MBP and expressed in the periplasm, it should titrate the activating effect of the periplasmic version of RcsF as MBPRcsCperi did. As shown in Fig. 1d 
Interaction of periplasmic RcsFDPRR with RcsCperi and YrfFperi detected by BiFC
BiFC is a method to visualize the location of protein interaction in living cells by fusing fragments of a fluorescent protein to the interaction partners [22] . RcsF has two disulfide bonds that are important for function in the C-terminal region, which are formed in the periplasm [23, 24] . To detect interaction in the periplasmic space we chose sfGFP [13] . Although most GFP variants are not fluorescent when exported by the Sec-dependent pathway [25] , sfGFP is fluorescent when exported to the periplasm through the Sec translocon [26, 27] . MBP SS was fused to the N terminus of sfGN and sfGC (see the Methods section). MBP SS-sfGN was expressed from P trc on a pBR322-derived plasmid, and MBP SS-sfGC was expressed from P trc on a p15A-derived plasmid.
First, as a positive control, a leucine zipper of the yeast transcriptional factor GCN4 [28, 29] was fused to the C termini of sfGN and sfGC, and the fusion proteins were expressed in a DrcsC DrcsD DrcsF DyrfF strain. Fluorescence was observed in the periphery of the cells (Fig. 2a) . Also observed were a few bright dots, which were possibly due to the aggregation of fusion proteins (see below). When the leucine zipper was removed from one of the fusion proteins, no fluorescence was observed (Fig. S2a) , indicating that the fluorescence derived from interaction of the leucine zippers.
Next, the mature form of RcsFDPRR was fused to MBP SSsfGN, and RcsCperi and YrfFperi were fused to MBP SSsfGC. RcsFDPRR was chosen because periplasmic RcsFDPRR shows a higher Rcs activating effect than periplasmic RcsF [21] . Coexpression of MBP SS-sfGN-RcsFDPRR plus MBP SS-sfGC-RcsCperi and MBP SS-sfGN-RcsFDPRR plus MBP SS-sfGC-YrfFperi in the DrcsC DrcsD DrcsF DyrfF strain led to fluorescence in the cell periphery (Fig. 2b) . Removal of either of RcsFDPRR, RcsCperi or YrfFperi resulted in loss of fluorescence (Fig. S2b) , indicating that the peripheral fluorescence derived from the interaction of RcsFDPRR with RcsCperi and YrfFperi.
Cells with peripheral fluorescence were treated with lysozyme. The peripheral fluorescence was lost from the spheroplasted cells, whereas rod-shaped cells kept the peripheral fluorescence (Fig. 2c ). This result indicates that the interactions of RcsFDPRR with RcsCperi and YrfFperi occur in the periplasm. In cells expressing enhanced yellow fluorescent protein (EYFP) without SS, the fluorescence observed in the cytoplasm was not lost after spheroplasting (Fig. 2c) . In contrast to the peripheral fluorescence, the bright dots were not lost from the spheroplasted cells, indicating that the dots were in the cytoplasm. In the negative control experiments for the BiFC experiments (Fig. S2 ) no bright dot was observed, indicating that neither sfGN nor sfGC form fluorescent dots. It is possible that an interaction of sfGN-fused RcsFDPRR with sfGC-fused RcsCperi or YrfFperi happened due to accumulation of these proteins in the same area of the cytoplasm and did not specifically reflect the in vivo situation with native RcsF and RcsC or YrfF.
Deletion in the periplasmic domain of RcsC abolished the activation effect of RcsF The results described above indicate that RcsF interacts with RcsCperi. This means that a defect in the periplasmic domain of RcsC should affect RcsF's activating effect. We deleted the central third of the periplasmic domain of RcsC (residues 160-231) and cloned the remaining sequence under the control of P BAD promoter. As a control the fulllength rcsC gene was also cloned. Both were fused to 3ÂFLAG tag in the C termini.
When RcsF is mislocalized to the CM due to a change of the lipoprotein-sorting signal, the Rcs system is strongly activated [7] . When this RcsFS2DM3Q was expressed with 100 µM IPTG in DrcsC DrcsF cells together with RcsC-3ÂFLAG, increasing the arabinose concentration from 0 to 0.00002 % resulted in increased Rcs activity. By contrast, when RcsCD160-231-3ÂFLAG was co-expressed, no activation was observed (Fig. 3a) To test whether the truncated RcsCD160-231 was degraded, we analysed the DrcsC DrcsF cells harbouring pRcsC or pRcsCD160-231 by SDS-PAGE followed by Western blotting using anti-FLAG antibody as the primary antibody (Fig. 3b) . Although RcsCD160-230 seemed slightly less stable than the wild-type RcsC, ample amounts of the fulllength product were detected. However, we could not exclude the possibility that the degradation products interfered with the full-length product in activating the Rcs system.
To examine whether RcsCD160-231 was active in phosphorelay signal transduction, we transformed DrcsC DrcsF cells harbouring pHR741 with pRcsC and pRcsCD160-231. pHR741 carries the djlA gene under IPTGinducible P 204 promoter. djlA overexpression leads to activation of the Rcs system [30, 31] which is dependent on RcsC [32] but independent of RcsF [3] . Activation of the Rcs system was observed in pRcsC transformants but, unexpectedly, not in pRcsCD160-231 transformants (data not shown). Therefore, we next examined the effect of the deletion of yrfF. DyrfF is lethal unless at least one of rcsC, rcsD or rcsB is simultaneously deleted. We tried to transform HN001 deleted for yrfF, rcsC and rcsF with pRcsC and pRcsCD160- 231 in the absence of arabinose. Both plasmids gave rise to transformant colonies. Transformants with pRcsC formed very small colonies only. Both pRcsC and pRcsCD160-231 transformants formed blue colonies on an LB agar plate containing X-Gal in the absence of arabinose (data not shown).
The pRcsC-transformants did not grow in liquid LB medium, even in the absence of arabinose. The pRcsCD160-231 transformants showed very high b-galactosidase activity in the absence of or at a very low concentration of arabinose (Fig. 3c) . Although the possibility that the poor growth of the transformants affected b-galactosidase assay could not be excluded, we concluded that the RcsCD160-231 was active in phosphorelay signal transduction.
The inability of RcsCD160-231 to activate the Rcs system with CM-mislocalized RcsF (Fig. 3a) suggests that RcsCD160-231 does not interact with RcsF and that the interaction of RcsC with RcsF is necessary for activation of the Rcs system.
Periplasmic domain of RcsD did not titrate the activating effect of RcsFDPRR
The membrane topology of the transmitter protein RcsD is similar to the membrane topology of RcsC. The amino acid sequences of the two proteins are similar [33] . in the N-terminal region of RcsD are predicted to be exposed to the periplasm. This segment (RcsDperi) is similar to RcsCperi (identity, 15.3 %; similarity, 61.8 %) (GENETYX). We suspected that RcsDperi might also interact with RcsF. The coding sequence for rcsDperi was fused to the malE gene under the control of P tac promoter in the plasmid pTM001. When MBP-RcsDperi was expressed in a DrcsF strain expressing periplasmically mislocalized RcsFDPRR, however, no suppression of Rcs activation was observed (Fig. 4a) .
To test whether the MBP-RcsDperi was degraded, we analysed the cells expressing MBP or MBP-RcsDperi by SDS-PAGE followed by Western blotting using anti-MBP antibody as the primary antibody (Fig. 4b) . Full-length MBP-RcsDperi fusion protein was detected with 50 µM IPTG, although faint bands of probable degradation products were also detected. These results indicate that RcsDperi does not interact with RcsF.
DISCUSSION
The OM lipoprotein RcsF is an essential component of the Rcs signal transduction system [1, 3] . It very likely senses environmental and mutational stresses and transmits the information to CM components of the Rcs system. Mislocalization of RcsF to the periplasm or the CM activates the Rcs system significantly, suggesting that RcsF interacts directly with the CM component(s) when transmitting the information [7, 34] . The interaction most probably occurs with the periplasmically exposed domain(s) of the CM component(s).
For this study we expressed MBP-RcsCperi fusion protein in the periplasm. This decreased or abolished the Rcs activation in response to an opgH mutation or the expression of periplasmically mislocalized RcsF and RcsFDPRR. This suggests that RcsCperi interacts with RcsF. In BiFC experiments, co-expression of sfGN-RcsFDPRR and sfGCRcsCperi in the periplasm resulted in fluorescence in the periphery of the cells, indicating interaction of RcsFDPRR and RcsCperi in the periplasm. We conclude that RcsF and the periplasmically exposed domain of RcsC interact directly in activating the Rcs system.
Cho et al. [8] reported that RcsF interacts with the large periplasmic domain of YrfF with 1 : 1 stoichiometry. They proposed that this alleviates YrfF's inhibitory effect and activates the Rcs system. We observed titration of RcsFDPRR's activating effect with MBP-YrfFperi. In BiFC experiments, co-expression of sfGN-RcsFDPRR and sfGC-YrfFperi in the periplasm resulted in fluorescence in the periphery of the cells. These results point to the direct interaction of RcsF and the periplasmically exposed domain of YrfF. RcsCD160-231 does not respond to CM-mislocalized RcsF, which activates wild-type RcsC significantly [7] . The central region of RcsCperi (residues 160-231) seems to be necessary for RcsC to receive information from RcsF. It is not inconceivable that the activation of the Rcs system might occur via the interaction of RcsFS2DM3Q with the CM protein YrfF, which then would activate the Rcs system. In the presence of RcsCD160-231 instead of RcsC, however, no Rcs activation was observed. It seems that in cells where RcsF interacts with YrfF, RcsF-RcsC interaction is still required for Rcs activation.
YrfF probably interacts with RcsC to inhibit its activation. Transmission of information from RcsF to YrfF does not abolish the interaction but modifies it. If the interaction were abolished, cells would die because deletion of yrfF is lethal unless rcsC, rcsD or rcsB is also deleted. In the absence of YrfF, a very low expression level of RcsCD160-231, which does not accept information from RcsF, led to very high Rcs activation. This result also indicates that RcsCD160-231 is not defective in phosphorelay.
RcsDperi is homologous with RcsCperi, but RcsDperi did not titrate the activating effect of periplasmically mislocalized RcsFDPRR. RcsDperi does not seem to interact with RcsF. Pescaretti et al. [35] described the possibility that RcsD could also work as sensor kinase to transfer a phosphoryl group to RcsB in the absence of RcsC, rather than as an auxiliary transmitter. Since RcsD seems to be unable to sense the information from RcsF, we are led to infer that RcsD may sense different stimuli from those sensed by RcsC, as the same paper suggests.
In summary, we have shown that RcsF interacts with RcsC as well as with YrfF. It seems that, even when RcsF interacts with YrfF, RcsF-RcsC interaction is still necessary for activation of the Rcs system.
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